Intuitive Surgical, Inc. (NASDAQ:ISRG) CEO Gary S. Guthart sold 28,152 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 4th. The stock was sold at an average price of $520.47, for a total value of $14,652,271.44. Following the transaction, the chief executive officer now owns 379,452 shares of the company’s stock, valued at $197,493,382.44. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Shares of ISRG opened at $509.36 on Friday. The firm has a market capitalization of $59.76 billion, a price-to-earnings ratio of 53.67, a price-to-earnings-growth ratio of 3.96 and a beta of 1.12. Intuitive Surgical, Inc. has a fifty-two week low of $380.00 and a fifty-two week high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 24th. The medical equipment provider reported $2.96 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $3.07 by ($0.11). The business had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.05 billion. Intuitive Surgical had a net margin of 30.29% and a return on equity of 18.11%. The company’s revenue was up 17.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.54 earnings per share. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 10.07 earnings per share for the current fiscal year.
Several brokerages recently issued reports on ISRG. Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Wednesday, November 21st. ValuEngine downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, December 7th. Piper Jaffray Companies lifted their price objective on Intuitive Surgical to $613.00 and gave the stock an “overweight” rating in a research report on Friday, October 19th. Canaccord Genuity upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $550.00 to $610.00 in a research report on Friday, October 19th. They noted that the move was a valuation call. Finally, Royal Bank of Canada restated a “hold” rating and set a $560.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 19th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $566.40.
COPYRIGHT VIOLATION NOTICE: “Intuitive Surgical, Inc. (ISRG) CEO Sells $14,652,271.44 in Stock” was originally published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.themarketsdaily.com/2019/02/08/intuitive-surgical-inc-isrg-ceo-sells-14652271-44-in-stock.html.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Further Reading: Trading Ex-Dividend Strategy
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.